Your browser doesn't support javascript.
loading
Ceftazidime-Avibactam plus Aztreonam for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria.
Sempere, Abiu; Viñado, Belén; Los-Arcos, Ibai; Campany, David; Larrosa, Nieves; Fernández-Hidalgo, Nuria; Rodríguez-Pardo, Dolors; González-López, Juan José; Nuvials, Xavier; Almirante, Benito; Escolà-Vergé, Laura.
Afiliação
  • Sempere A; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Viñado B; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Los-Arcos I; Microbiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Campany D; Spanish Network for the Research in Infectious Diseases (REIPI RD16/0016/0003), Instituto de Salud Carlos III, Madrid, Spain.
  • Larrosa N; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Fernández-Hidalgo N; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Rodríguez-Pardo D; Spanish Network for the Research in Infectious Diseases (REIPI RD16/0016/0003), Instituto de Salud Carlos III, Madrid, Spain.
  • González-López JJ; Pharmacy Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Nuvials X; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Almirante B; Microbiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Escolà-Vergé L; Spanish Network for the Research in Infectious Diseases (REIPI RD16/0016/0003), Instituto de Salud Carlos III, Madrid, Spain.
Antimicrob Agents Chemother ; 66(10): e0075122, 2022 10 18.
Article em En | MEDLINE | ID: mdl-36102635

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Beta-Lactamases / Aztreonam Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Beta-Lactamases / Aztreonam Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article